New Zealand markets closed

Insmed Incorporated (INSM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
26.19-0.19 (-0.72%)
As of 10:06AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.86B
Enterprise value 4.34B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)12.14
Price/book (mrq)25.45
Enterprise value/revenue 14.23
Enterprise value/EBITDA -5.08

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 340.84%
S&P500 52-week change 326.43%
52-week high 332.00
52-week low 318.09
50-day moving average 326.60
200-day moving average 326.06

Share statistics

Avg vol (3-month) 31.79M
Avg vol (10-day) 31.57M
Shares outstanding 5148.56M
Implied shares outstanding 6149.2M
Float 8147.2M
% held by insiders 11.09%
% held by institutions 1104.73%
Shares short (15 Apr 2024) 49.4M
Short ratio (15 Apr 2024) 45.7
Short % of float (15 Apr 2024) 46.43%
Short % of shares outstanding (15 Apr 2024) 46.33%
Shares short (prior month 15 Mar 2024) 48.84M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 303 Mar 2011

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -236.74%
Operating margin (ttm)-208.48%

Management effectiveness

Return on assets (ttm)-31.79%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)315.49M
Revenue per share (ttm)2.20
Quarterly revenue growth (yoy)15.80%
Gross profit (ttm)N/A
EBITDA -671.89M
Net income avi to common (ttm)-746.89M
Diluted EPS (ttm)-5.34
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)595.73M
Total cash per share (mrq)4.01
Total debt (mrq)1.37B
Total debt/equity (mrq)N/A
Current ratio (mrq)1.80
Book value per share (mrq)-3.13

Cash flow statement

Operating cash flow (ttm)-573.98M
Levered free cash flow (ttm)-415.46M